{"id":96237,"date":"2024-12-16T12:56:38","date_gmt":"2024-12-16T12:56:38","guid":{"rendered":"https:\/\/insights.greyb.com\/?post_type=ht_kb&p=96237"},"modified":"2024-12-16T12:56:41","modified_gmt":"2024-12-16T12:56:41","slug":"synaffix-patents","status":"publish","type":"ht_kb","link":"https:\/\/insights.greyb.com\/synaffix-patents\/","title":{"rendered":"Synaffix Patents – Insights & Stats (Updated 2024)"},"content":{"rendered":"\n

Synaffix has a total of 293 patents globally, out of which 130 have been granted. Of these 293 patents, more than 77% patents are active. United States of America is where Synaffix has filed the maximum number of patents, followed by Europe (EPO) and China. Parallelly, Europe (EPO) seems to be the main focused R&D centre and also Netherlands is the origin country of Synaffix.<\/p>\n\n\n\n

Synaffix was founded in the year 2010. The company is a biotech company that focuses on developing advanced techniques for linking molecules together. They specialize in creating innovative methods for mild and efficient protein conjugation, which are used in applications like drug development.<\/p>\n\n\n\n

Do read about some of the most popular patents of Synaffix which have been covered by us in this article and also you can find Synaffix patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Synaffix patent portfolio.<\/p>\n\n\n\n

How many patents does <\/strong>Synaffix <\/strong>have?<\/strong><\/h3>\n\n\n\n

Synaffix has a total of 293 patents globally. These patents belong to 41 unique patent families. Out of 293 patents, 227 patents are active.<\/p>\n\n\n\n

How Many Patents did <\/strong>Synaffix <\/strong>File Every Year?<\/strong><\/h3>\n\n\n\n
\"Synaffix<\/a><\/figure>\n\n\n\n

Are you wondering why there is a drop in patent filing for the last two years? <\/strong>It is because a patent application can take up to 18 months to get published. Certainly, it doesn\u2019t suggest a decrease in the patent filing.<\/p>\n\n\n\n

Year of Patents Filing or Grant<\/strong><\/td>Synaffix Applications Filed<\/strong><\/td>Synaffix Patents Granted<\/strong><\/td><\/tr>
2024<\/td>11<\/td>12<\/td><\/tr>
2023<\/td>29<\/td>24<\/td><\/tr>
2022<\/td>20<\/td>17<\/td><\/tr>
2021<\/td>33<\/td>14<\/td><\/tr>
2020<\/td>17<\/td>8<\/td><\/tr>
2019<\/td>5<\/td>8<\/td><\/tr>
2018<\/td>13<\/td>23<\/td><\/tr>
2017<\/td>26<\/td>11<\/td><\/tr>
2016<\/td>23<\/td>9<\/td><\/tr>
2015<\/td>36<\/td>2<\/td><\/tr>
2014<\/td>29<\/td>2<\/td><\/tr>
2013<\/td>34<\/td>–<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

How many Synaffix<\/strong> <\/strong>patents are Alive\/Dead?<\/strong><\/h3>\n\n\n\n
\"Synaffix<\/a><\/figure>\n\n\n\n

<\/strong>How Many Patents did <\/strong>Synaffix <\/strong>File in Different Countries?<\/strong><\/strong><\/h3>\n\n\n\n
\"Synaffix<\/a><\/figure>\n\n\n\n

Countries in which <\/strong>Synaffix <\/strong>Filed Patents<\/strong><\/h3>\n\n\n\n
Country<\/strong><\/td>Patents<\/strong><\/td><\/tr>
United States of America<\/td>47<\/td><\/tr>
Europe (EPO)<\/td>47<\/td><\/tr>
China<\/td>25<\/td><\/tr>
Japan<\/td>25<\/td><\/tr>
India<\/td>21<\/td><\/tr>
Germany<\/td>15<\/td><\/tr>
Austria<\/td>11<\/td><\/tr>
Spain<\/td>6<\/td><\/tr>
Poland<\/td>4<\/td><\/tr>
Denmark<\/td>4<\/td><\/tr>
Singapore<\/td>3<\/td><\/tr>
Croatia<\/td>3<\/td><\/tr>
Netherlands<\/td>3<\/td><\/tr>
Portugal<\/td>3<\/td><\/tr>
Hungary<\/td>3<\/td><\/tr>
South Africa<\/td>3<\/td><\/tr>
Australia<\/td>3<\/td><\/tr>
Israel<\/td>3<\/td><\/tr>
Norway<\/td>3<\/td><\/tr>
Slovakia<\/td>2<\/td><\/tr>
Malta<\/td>2<\/td><\/tr>
Serbia<\/td>2<\/td><\/tr>
Slovenia<\/td>2<\/td><\/tr>
Cyprus<\/td>2<\/td><\/tr>
Lithuania<\/td>2<\/td><\/tr>
Mexico<\/td>2<\/td><\/tr>
Albania<\/td>2<\/td><\/tr>
Estonia<\/td>1<\/td><\/tr>
Finland<\/td>1<\/td><\/tr>
Italy<\/td>1<\/td><\/tr>
Korea (South)<\/td>1<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

\u00a0Where are Research Centres of Synaffix Patents\u00a0Located?<\/strong><\/h3>\n\n\n\n
\"R&D<\/a><\/figure>\n\n\n\n

<\/strong>10 Best <\/strong>Synaffix <\/strong>Patents<\/strong><\/strong><\/h3>\n\n\n\n

WO2014065661A1<\/a> is the most popular patent in the Synaffix portfolio. It has received 326 citations so far from companies like Regeneron Pharmaceuticals, Innate Pharma and Shanghai Miracogen Inc.<\/strong><\/p>\n\n\n\n

Below is the list of 10 most cited patents of Synaffix:<\/strong><\/p>\n\n\n\n

Publication Number<\/strong><\/td>Citation Count<\/strong><\/td><\/tr>
WO2014065661A1<\/a><\/td>326<\/td><\/tr>
WO2011136645A1<\/a><\/td>173<\/td><\/tr>
WO2016053107A1<\/a><\/td>103<\/td><\/tr>
WO2016170186A1<\/a><\/td>95<\/td><\/tr>
US9222940B2<\/a><\/td>75<\/td><\/tr>
WO2020094670A1<\/a><\/td>67<\/td><\/tr>
US20160107999A1<\/a><\/td>62<\/td><\/tr>
US10266502B2<\/a><\/td>56<\/td><\/tr>
US8859629B2<\/a><\/td>56<\/td><\/tr>
US9636421B2<\/a><\/td>48<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

What are Synaffix key innovation segments?<\/strong><\/h3>\n\n\n\n\r\n